Measles vaccination in an increasingly immunized and developed world

References

• World Health Organization. Global measles and rubella strategic plan; Geneva, Switzerland: WHO Press. 2012.
   Google Scholar
• Dabbagh A, Patel MK, Dumolard L, Gacic-Dobo M, Mulders MN, J-M O-B, Kretsinger K, Papania MJ, Rota PA, Goodson JL. Progress toward regional measles elimination—worldwide, 2000–2016. MMWR Morb Mortal Wkly Rep. 2017;66(42):1148.
   PubMed Web of Science ®Google Scholar
• Li S, Ma C, Hao L, Su Q, An Z, Ma F, Xie S, Xu A, Zhang Y, Ding Z. Demographic transition and the dynamics of measles in six provinces in China: A modeling study. PLoS Med. 2017;14(4):e1002255.
   PubMed Web of Science ®Google Scholar
• United Nations Development Programme. 2016 Human Development Report. 2016.
   Google Scholar
• Yanagi Y, Takeda M, Ohno S. Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol. 2006;87(10):2767–2779.
   PubMedGoogle Scholar
• de Vries RD, Mesman AW, Geijtenbeek TB, Duprex WP, de Swart RL. The pathogenesis of measles. Curr Opin Virol. 2012;2(3):248–255.
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Cairns L, Hinman A, Nkowane B, J-M O, Reingold AL. Measles and rubella global strategic plan 2012–2020 midterm review report: background and summary. Vaccine. 2018;36:A35–A42.
   PubMed Web of Science ®Google Scholar
• Pan American Health Organization. Region of the Americas is declared free of measles. Washington, DC: Regional Office for the Americas of the World Health Organization; 2016.
   Google Scholar
• Siqueira MM, Brown DW. Measles and rubella in the Americas: the path to elimination. Human Virology in Latin America: Springer. 2017;p 291–306.
   Google Scholar
• Lancella L, Di Camillo C, Vittucci A, Boccuzzi E, Bozzola E, Villani A. Measles lessons in an anti-vaccination era: public health is a social duty, not a political option. Ital J Pediatr. 2017;43(1):102.
   PubMedGoogle Scholar
• Hayman D, Marshall J, French N, Carpenter T, Roberts M, Kiedrzynski T. Global importation and population risk factors for measles in New Zealand: a case study for highly immunized populations. Epidemiol Infect. 2017;145(9):1875–1885.
   PubMed Web of Science ®Google Scholar
• Sugerman DE, Barskey AE, Delea MG, Ortega-Sanchez IR, Bi D, Ralston KJ, Rota PA, Waters-Montijo K, LeBaron CW. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics. 2010;125(4):747–755.
   PubMed Web of Science ®Google Scholar
• Tanaka-Taya K. [Current situation of measles in Japan, 2017]. Uirusu. 2017;67(1):17–24.
   PubMedGoogle Scholar
• Hagan JE, Greiner A, Luvsansharav U-O, Lake J, Lee C, Pastore R, Takashima Y, Sarankhuu A, Demberelsuren S, Smith R. Use of a diagonal approach to health system strengthening and measles elimination after a large nationwide outbreak in Mongolia. Emerg Infect Dis. 2017;23(Suppl 1):S77.
   Google Scholar
• Bartlett MS. Mealses periodicity and community size. J Royal Stat Soc Ser a-General. 1957;120(1):48–70.
   Google Scholar
• Pelletier L, Chung P, Duclos P, Manga P, Scott J. A benefit-cost analysis of two-dose measles immunization in Canada. Vaccine. 1998;16(9–10):989–996.
   PubMed Web of Science ®Google Scholar
• Organization WH. Measles vaccines: WHO position paper. Weekly Epidemiological Record. 2009;84(35):349–360.
   PubMedGoogle Scholar
• Agur Z, Cojocaru L, Mazor G, Anderson RM, Danon YL. Pulse mass measles vaccination across age cohorts. Proc Natl Acad Sci U S A. 1993;90(24):11698–11702.
   PubMed Web of Science ®Google Scholar
• Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect. 1995;114(2):319–344.
   PubMed Web of Science ®Google Scholar
• Wallinga J, Levy-Bruhl D, Gay N, Wachmann C. Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some Western European countries. Epidemiol Infect. 2001;127(02):281–295.
   PubMedGoogle Scholar
• Edmunds WJ, Gay NJ, Kretzschmar M, Pebody R, Wachmann H. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect. 2000;125(03):635–650.
   PubMedGoogle Scholar
• Hayman D, Marshall J, French N, Carpenter T, Roberts M, Kiedrzynski T. Cost-benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand. Vaccine. 2017;35(37):4913–4922.
   PubMed Web of Science ®Google Scholar
• Kumakura S, Shibata H, Onoda K, Nishimura N, Matsuda C, Hirose M. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. Epidemiol Infect. 2013;142(1):12–19.
   PubMed Web of Science ®Google Scholar
• Kinoshita R, Nishiura H. Assessing age-dependent susceptibility to measles in Japan. Vaccine. 2017;35(25):3309–3317.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhang Y, Huang F, Wang H, Liu D, Li J, Rodewald L, Wu J, Deng Y, Xu W. Endemic and imported measles virus–associated outbreaks among adults, Beijing, China, 2013. Emerg Infect Dis. 2015;21(3):477.
   PubMed Web of Science ®Google Scholar
• Keeling MJ, Grenfell B. Disease extinction and community size: modeling the persistence of measles. Science (80-). 1997;275(5296):65–67.
   PubMed Web of Science ®Google Scholar
• Black FL. Measles endemicity in insular populations: critical community size and its evolutionary implication. J Theor Biol. 1966;11(2):207–211.
   PubMed Web of Science ®Google Scholar
• Glass K, Kappey J, Grenfell B. The effect of heterogeneity in measles vaccination on population immunity. Epidemiol Infect. 2004;132(04):675–683.
   PubMedGoogle Scholar
• Hens N, Abrams S, Santermans E, Theeten H, Goeyvaerts N, Lernout T, Leuridan E, van Kerckhove K, Goossens H, Damme V. P and others. Assessing the risk of measles resurgence in a highly vaccinated population: belgium anno 2013. Euro Surveill. 2015;20(1): 1–10.
   PubMedGoogle Scholar
• Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, van Damme P. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect. 2011;139(4):494–504.
   PubMed Web of Science ®Google Scholar
• Pinchoff J, Chipeta J, Banda GC, Miti S, Shields T, Curriero F, Moss WJ. Spatial clustering of measles cases during endemic (1998–2002) and epidemic (2010) periods in Lusaka, Zambia. BMC Infect Dis. 2015;15(1):121.
   PubMedGoogle Scholar
• Trentini F, Poletti P, Merler S, Melegaro A. Measles immunity gaps and the progress towards elimination: a multi-country modelling analysis. Lancet Infect Dis. 2017;17(10):1089–1097.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Measles and rubella surveillance – 2017. Stockholm, Sweden: ECDC; 2018. 2018 Apr.
   Google Scholar
• Fiebelkorn AP, Redd SB, Gastañaduy PA, Clemmons N, Rota PA, Rota JS, Bellini WJ, Wallace GSA. Comparison of postelimination measles epidemiology in the United States, 2009–2014 Versus 2001–2008. J Pediatric Infect Dis Soc. 2017;6(1):40–48.
   PubMed Web of Science ®Google Scholar
• Nishiura H, Mizumoto K, Asai Y. Assessing the transmission dynamics of measles in Japan, 2016. Epidemics. 2017;20:67–72.
   PubMed Web of Science ®Google Scholar
• Kaida A, Iritani N, Kanbayashi D, Yamamoto SP, Hirai Y, Hakui N, Fujimori R, Mori H, Hirokawa H, Ogasawara J. Ten-year surveillance of measles virus from 2007–2016 in Osaka City, Japan. Jpn J Infect Dis. 2018;71(2):152–154.
   PubMed Web of Science ®Google Scholar
• Gastañaduy PA, Paul P, Fiebelkorn AP, Redd SB, Lopman BA, Gambhir M, Wallace GS. Assessment of the status of measles elimination in the United States, 2001–2014. Am J Epidemiol. 2017;185(7):562–569.
   PubMed Web of Science ®Google Scholar
• Ma R, Lu L, Suo L, Li X, Yang F, Zhou T, Zhai L, Bai H, Pang X. An expensive adult measles outbreak and response in office buildings during the era of accelerated measles elimination, Beijing, China. Vaccine. 2017;35(8):1117–1123.
   PubMed Web of Science ®Google Scholar
• Tang L, Zhou Y, Pan Y, Zhu H. Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015. Vaccine. 2017;35(22):2925–2929.
   PubMed Web of Science ®Google Scholar
• Hwai LS. Measles outbreak in Japan, Taiwan puts thousands in quarantine, delays travel plans, Strait Times 2018.
   Google Scholar
• Gidding HF, Quinn HE, Hueston L, Dwyer DE, McIntyre PB. Declining measles antibodies in the era of elimination: australia’s experience. Vaccine. 2018;36(4):507–513.
   PubMed Web of Science ®Google Scholar
• Winter A, Martinez M, Cutts F, Moss W, Ferrari M, McKee A, Lessler J, Hayford K, Wallinga J, Metcalf C. 2018. Benefits and challenges in using sero-prevalence data to inform models for measles and rubella elimination. J Infect Dis. 218(3):355–364.
   PubMed Web of Science ®Google Scholar
• Waaijenborg S, Hahné SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, de Melker HE, Wallinga J. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208(1):10–16.
   PubMed Web of Science ®Google Scholar
• Inaida S, Matsuno S, Kobune F. Measles elimination and immunisation: national surveillance trends in Japan, 2008–2015. Epidemiol Infect. 2017;145(11):2374–2381.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Sahota A, Stephenson I, Brown KE, Tang JW. Measles–A tale of two sisters, vaccine failure, and the resurgence of an old foe. J Infect. 2017;74(3):318–320.
   PubMed Web of Science ®Google Scholar
• Breakwell L, Moturi E, Helgenberger L, Gopalani SV, Hales C, Lam E, Sharapov U, Larzelere M, Johnson E, Measles outbreak MC. Associated with vaccine failure in adults–federated states of Micronesia, February-August 2014. MMWR Morb Mortal Wkly Rep. 2015;64(38):1088–1092.
   PubMed Web of Science ®Google Scholar
• Fowotade A, Okonko I, Nwabuisi C, Bakare R, Fadeyi A, Adu F. Measles vaccine potency and sero-conversion rates among infants receiving measles immunization in Ilorin, Kwara State, Nigeria. Journal of Immunoassay and Immunochemistry. 2015;36(2):195–209.
   PubMedGoogle Scholar
• Associated Press. Romania’s measles outbreak kills dozens of children, 2018.
   Google Scholar
• Stanescu A, Janta D, Lupulescu E, Necula G, Lazar M, Molnar G, Pistol A. Ongoing measles outbreak in Romania, 2011. Eurosurveillance. 2011;16(31):19932.
   Web of Science ®Google Scholar
• Pistol A, Hennessey K, Pitigoi D, Ion‐Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. J Infect Dis. 2003;187(Supplement_1):S217–S222.
   PubMedGoogle Scholar
• Dayan GH, Ortega-Sánchez IR, LeBaron CW, Quinlisk MP. The cost of containing one case of measles: the economic impact on the public health infrastructure—iowa, 2004. Pediatrics. 2005;116(1):e1–e4.
   PubMed Web of Science ®Google Scholar
• Ortega-Sanchez IR, Vijayaraghavan M, Barskey AE, Wallace GS. The economic burden of sixteen measles outbreaks on United States public health departments in 2011. Vaccine. 2014;32(11):1311–1317.
   PubMed Web of Science ®Google Scholar
• Lo NC, Hotez PJ. Public health and economic consequences of vaccine hesitancy for measles in the United States. JAMA Pediatr. 2017;171(9):887–892.
   PubMed Web of Science ®Google Scholar
• Jansen VA, Stollenwerk N, Jensen HJ, Ramsay M, Edmunds W, Rhodes C. Measles outbreaks in a population with declining vaccine uptake. Science (80-). 2003;301(5634):804.
   PubMed Web of Science ®Google Scholar
• Thompson KM, Odahowski CL. Systematic review of health economic analyses of measles and rubella immunization interventions. Risk Anal. 2016;36(7):1297–1314.
   PubMed Web of Science ®Google Scholar
• Hinman AR, Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J Infect Dis. 2004;189(Supplement 1):S131–S145.
   PubMedGoogle Scholar
• Bae GR, Choe YJ, Go UY, Kim YI, Lee JK. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study. Vaccine. 2013;31(24):2661–2666.
   PubMed Web of Science ®Google Scholar
• Ferrari MJ, Grais RF, Bharti N, Conlan AJ, Bjørnstad ON, Wolfson LJ, Guerin PJ, Djibo A, Grenfell BT. The dynamics of measles in sub-Saharan Africa. Nature. 2008;451(7179):679.
   PubMed Web of Science ®Google Scholar
• Bharti N, Tatem AJ, Ferrari MJ, Grais RF, Djibo A, Grenfell BT. Explaining seasonal fluctuations of measles in Niger using nighttime lights imagery. Science (80-). 2011;334(6061):1424–1427.
   PubMed Web of Science ®Google Scholar